Floyd Eric's most recent trade in Virpax Pharmaceuticals Inc was a trade of 45,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 29, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Virpax Pharmaceuticals Inc | Floyd Eric | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Virpax Pharmaceuticals Inc | Eric Floyd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Virpax Pharmaceuticals Inc | Eric Floyd | Director | Purchase of securities on an exchange or from another person at price $ 1.36 per share. | 18 May 2022 | 4,479 | 8,018 | - | 1.4 | 6,107 | Common Stock, $0.00001 par value |
| Virpax Pharmaceuticals Inc | Eric Floyd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 15,124 | 15,124 | - | - | Stock Option (right to buy) | |
| Virpax Pharmaceuticals Inc | Eric Floyd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2021 | 11,216 | 11,216 | - | - | Stock Option (right to buy) |